胰岛素样生长因子I通过抑制食欲素神经元AMPK缓解创伤后应激
该研究在小鼠中显示,食欲素神经元缺乏功能性IGF-I受体的Firoc小鼠对IGF-I的抗焦虑作用无反应,并出现可被食欲素神经元抑制所改善的PTSD样行为;全身IGF-I治疗改善野生型PTSD小鼠的PTSD样行为,药理学抑制AMPK可模拟IGF-I并使PTSD小鼠恐惧行为正常化。作者据此提出IGF-I通过依赖情境的方式平衡食欲素神经元的兴奋/抑制输入来促成应对行为,为通过调控AMPK治疗PTSD提供新思路。
要点
- 食欲素神经元IGF-I受体缺失小鼠出现PTSD样行为,抑制食欲素神经元可改善。
- 全身IGF-I治疗改善野生型PTSD小鼠的PTSD样行为。
- 药理学抑制AMPK可模拟IGF-I,使PTSD小鼠恐惧行为正常化。
核心结论
- 作者认为IGF-I通过依赖情境的方式平衡食欲素神经元的兴奋/抑制输入来促成应对行为,为通过调控AMPK治疗PTSD提供新治疗途径。
研究设计与样本
- 研究使用缺乏食欲素神经元功能性IGF-I受体的Firoc小鼠、野生型PTSD小鼠模型及naïve野生型小鼠开展动物实验。
主要发现
- Firoc小鼠对IGF-I的抗焦虑作用无反应,并出现可被食欲素神经元抑制所改善的PTSD样行为。
- 全身IGF-I治疗改善野生型PTSD小鼠的PTSD样行为。
- 全身IGF-I通过抑制AMPK增加GABA(B)受体亚基去磷酸化,改变naïve野生型小鼠食欲素神经元的GABA/谷氨酸突触结构。
- 药理学抑制AMPK可模拟IGF-I,使PTSD小鼠恐惧行为正常化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Maladaptive coping behaviors are probably involved in post-traumatic stress disorders (PTSD), but underlying mechanisms are incompletely understood. We now report that mice lacking functional insulin-like growth factor I (IGF-I) receptors in orexin neurons of the lateral hypothalamus (Firoc mice) are unresponsive to the anxiolytic actions of IGF-I and develop PTSD-like behavior that is ameliorated by inhibition of orexin neurons. Conversely, systemic IGF-I treatment ameliorated PTSD-like behavior in a wild-type mouse model of PTSD (PTSD mice). Further, systemic IGF-I modified the GABA/Glutamate synaptic structure in orexin neurons of naïve wild-type mice by increasing the dephosphorylation of GABA(B) receptor subunit through inhibition of AMP-kinase (AMPK). Significantly, pharmacological inhibition of AMPK mimicked IGF-I, normalizing fear behavior in PTSD mice. Thus, we suggest that IGF-I enables coping behaviors by balancing E/I input onto orexin neurons in a context-dependent manner. These observations provide a novel therapeutic approach to PTSD through modulation of AMPK.
引用
- Fernández de Sevilla ME, Pignatelli J, Zegarra-Valdivia JA, et al. Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons. Mol Psychiatry. 2022. PMID: 35115701. doi:10.1038/s41380-022-01442-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。